Skip to content

Intravenous Lidocaine in Open Lung Resection Surgery

Intravenous Lidocaine Reduces Pain Scores and Opioid Consumption in Open Lung Resection Surgery: A Prospective Randomized Double-Blind Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04480281
Enrollment
60
Registered
2020-07-21
Start date
2020-01-10
Completion date
2020-05-15
Last updated
2020-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lidocaine, Pain, Postoperative

Brief summary

Management of postoperative pain in 2020 remains a challenge for anesthesiologists in the perioperative period. Lidocaine is an amide local anesthetic, it is one of the oldest adjuvant analgesics and is known to possess analgesic, anti-hyperalgesic and anti-inflammatory properties. Lidocaine is proven to be as effective as epidural analgesia in colorectal surgery. However, no study has evaluated the effect of a continuous lidocaine infusion for open lung resection in the post-operative period. The present study aims to evaluate the influence of IV lidocaine given during and 24 hours after surgery, on pain scores, opioid consumption, and possible benefits on patient outcome via the opioid-sparing effect in open thoracic surgery

Interventions

DRUGLidocaine Iv

Patients in the Lidocaine group received a bolus of lidocaine 1% 1.5mg/kg at the induction of general anesthesia followed by a continuous infusion of lidocaine 1% 2mg/kg/h just before surgical incision and continued until 24h after the surgery

DRUGNormal Saline

Patients in Group Placebo received an equal bolus volume of normal saline solution at induction, and then a continuous infusion started before surgical incision and maintained up until 24h postoperatively

Sponsors

Saint-Joseph University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* American society of anesthesiologists (ASA) scores of I, II or III. * Left or right posterolateral thoracotomy with postoperative monitoring in the intensive care unit (ICU) for at least 24 hours (h).

Exclusion criteria

* patient's refusal to participate * ASA score of IV or higher * severe hepatic or renal insufficiency * allergy to lidocaine, morphine or NSAIDs * cardiac arrhythmias or * epilepsy, * delayed extubation for more than 2 h postoperatively * urgent surgery

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption in the post operative periodDoses were measured for twenty four hours in the post operative periodTotal dose of morphine in the post operative period is measured for patients in both arms
Pain scores at rest and at coughMeasurements were made for 24 hours in the post operative periodAnalogue visual scale ( a 10cm scale , zero representing no pain and 10 representing the worst imaginable pain)) was used to measure pain scores for each patient at rest and at cough

Secondary

MeasureTime frameDescription
Pulmonary complicationsMeasurements were recorded for 24 hours in the post operative periodArterial partial carbon dioxide pressure (PCO2) measurements were recorded for patients in both arms

Countries

Lebanon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026